These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 9069518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A, Arranz M, Alvarez JJ, Perales J, Villar J, Herrera E, Lasunción MA.
    Clin Chim Acta; 1996 Apr 30; 248(2):157-74. PubMed ID: 8740580
    [Abstract] [Full Text] [Related]

  • 6. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S, van Tol A, Sluiter W, Dullaart R.
    Atherosclerosis; 1998 Sep 30; 140(1):71-9. PubMed ID: 9733217
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
    Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP.
    Atherosclerosis; 2000 Dec 30; 153(2):491-8. PubMed ID: 11164439
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment with Sandostatin LAR on small dense LDL and remnant-like lipoproteins in patients with acromegaly.
    Tan KC, Pang RW, Tiu SC, Lam KS.
    Clin Endocrinol (Oxf); 2003 Nov 30; 59(5):558-64. PubMed ID: 14616878
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly.
    Parkinson C, Drake WM, Wieringa G, Yates AP, Besser GM, Trainer PJ.
    Clin Endocrinol (Oxf); 2002 Mar 30; 56(3):303-11. PubMed ID: 11940041
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women.
    Carr MC, Ayyobi AF, Murdoch SJ, Deeb SS, Brunzell JD.
    Arterioscler Thromb Vasc Biol; 2002 Apr 01; 22(4):667-73. PubMed ID: 11950708
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. GH levels and insulin sensitivity are differently associated with biomarkers of cardiovascular disease in active acromegaly.
    Boero L, Manavela M, Meroño T, Maidana P, Gómez Rosso L, Brites F.
    Clin Endocrinol (Oxf); 2012 Oct 01; 77(4):579-85. PubMed ID: 22510144
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.